Skip to content
MedsAcross

Medicine

Beyaz kit

Available on requestPrescription onlyUS FDA

Beyaz kit is a prescription medicine containing Drospirenone/ethinyl estradiol/levomefolate and Levomefolate, marketed by Bayer HealthCare Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).

Key facts

Active ingredient (INN)
Drospirenone/ethinyl estradiol/levomefolate and Levomefolate
Brand
Beyaz
Dosage form
Kit
Packs
90 blister pack, 3 blister pack, 12 package and 1 more
Marketing authorisation holder
Bayer HealthCare Pharmaceuticals
Manufacturer
Bayer HealthCare Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
7 October 2010
Identifiers
RxCUI 1013626, 1013628, 1013629 +1DailyMed set ID 8132454a-6135-4bac-b206-83a55eb8dbc6NDC 50419-407Application NDA022532

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
90 blister pack in 1 package / 1 kit in 1 blister pack50419-407-00Bayer HealthCare Pharmaceuticals7 October 2010
3 blister pack in 1 package / 1 kit in 1 blister pack50419-407-03Bayer HealthCare Pharmaceuticals7 October 2010
90 blister pack in 1 package / 1 kit in 1 blister pack50419-407-70Bayer HealthCare Pharmaceuticals7 October 2010
12 package in 1 carton / 5 blister pack in 1 package / 1 kit in 1 blister pack50419-407-75Bayer HealthCare Pharmaceuticals7 October 2010

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Drospirenone/ethinyl estradiol/levomefolate and Levomefolate kit.

Compare all 2

Clinical summary

Drospirenone/ethinyl estradiol/levomefolate and Levomefolate is a fixed-dose combination medicine indicated by females of reproductive potential to prevent pregnancy, among other approved uses. It is available as kits. MedsAcross supplies Drospirenone/ethinyl estradiol/levomefolate and Levomefolate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Drospirenone/ethinyl estradiol/levomefolate and Levomefolate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Beyaz kit for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.